Resolution Bioscience and LabCorp Will Collaborate to Commercialize the Resolution ctDx Lung™ Liquid Biopsy Assay
LabCorp and QIAGEN Announce New Therascreen PIK3CA Mutation Analysis Companion Diagnostic For Metastatic Breast Cancer
LabCorp Announces Availability of New QIAGEN therascreen FGFR mutation analysis companion diagnostic for Bladder Cancer
Please join us for a 30 minute webinar of your choice!
Next session: Risk Stratification for Patients with Cancer using Artificial Intelligence